HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome).

AbstractBACKGROUND:
Immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome) is a rare autosomal recessive disease characterised by facial dysmorphism, immunoglobulin deficiency and branching of chromosomes 1, 9 and 16 after PHA stimulation of lymphocytes. Hypomethylation of DNA of a small fraction of the genome is an unusual feature of ICF patients which is explained by mutations in the DNA methyltransferase gene DNMT3B in some, but not all, ICF patients.
OBJECTIVE:
To obtain a comprehensive description of the clinical features of this syndrome as well as genotype-phenotype correlations in ICF patients.
METHODS:
Data on ICF patients were obtained by literature search and additional information by means of questionnaires to corresponding authors.
RESULTS AND CONCLUSIONS:
45 patients all with proven centromeric instability were included in this study. Facial dysmorphism was found to be a common characteristic (n = 41/42), especially epicanthic folds, hypertelorism, flat nasal bridge and low set ears. Hypo- or agammaglobulinaemia was demonstrated in nearly all patients (n = 39/44). Opportunistic infections were seen in several patients, pointing to a T cell dysfunction. Haematological malignancy was documented in two patients. Life expectancy of ICF patients is poor, especially those with severe infections in infancy or chronic gastrointestinal problems and failure to thrive. Early diagnosis of ICF is important since early introduction of immunoglobulin supplementation can improve the course of the disease. Allogeneic stem cell transplantation should be considered as a therapeutic option in patients with severe infections or failure to thrive. Only 19 of 34 patients showed mutations in DNMT3B, suggesting genetic heterogeneity. No genotype-phenotype correlation was found between patients with and without DNMT3B mutations.
AuthorsM M Hagleitner, A Lankester, P Maraschio, M Hultén, J P Fryns, C Schuetz, G Gimelli, E G Davies, A Gennery, B H Belohradsky, R de Groot, E J A Gerritsen, T Mattina, P J Howard, A Fasth, I Reisli, D Furthner, M A Slatter, A J Cant, G Cazzola, P J van Dijken, M van Deuren, J C de Greef, S M van der Maarel, C M R Weemaes
JournalJournal of medical genetics (J Med Genet) Vol. 45 Issue 2 Pg. 93-9 (Feb 2008) ISSN: 1468-6244 [Electronic] England
PMID17893117 (Publication Type: Journal Article)
Chemical References
  • DNA (Cytosine-5-)-Methyltransferases
  • DNA methyltransferase 3B
Topics
  • Adolescent
  • Adult
  • Centromere (genetics)
  • Child
  • Child, Preschool
  • Chromosomal Instability
  • Craniofacial Abnormalities (genetics, pathology)
  • DNA (Cytosine-5-)-Methyltransferases (genetics)
  • Female
  • Genotype
  • Humans
  • Immunologic Deficiency Syndromes (genetics)
  • Infant
  • Male
  • Mutation
  • Phenotype
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: